Back to search
Drug Intolerance
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Drug Intolerance trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Drug Intolerance trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Only 2% of Americans meet the recommended levels of whole grain consumption, despite its association with reduced risk of type 2 diabetes. This study aims to as…
The goal of this observational study is to learn whether personality traits are related to eye side effects from glaucoma medications in adults who currently us…
The goal of this study is to learn whether eating a small serving of almonds before meals can improve blood sugar control in adults who have early signs of prob…
Drug-drug interactions often limit statin optimization in a population of patients prescribed cytochrome P3A4 inhibitors, which include immunosuppressive agents…
It is known from the literature that treatment with antipsychotic drugs (AP) induces, even before changes in blood chemistry parameters, changes in gene transcr…
The DESIFOR pilot study was conducted to determine the feasibility of utilizing an n-of-1 trial to facilitate tolerance of unblinded rosuvastatin in patients wi…
The goal of this clinical trial is to learn whether guanfacine or cromolyn sodium can improve symptoms and physical functioning in adults with Postural Orthosta…
This is a randomized, double-blind, placebo-controlled parallel-group Phase II study. The study aims to evaluate the efficacy and safety of TLL-018 in adult pat…